NASDAQ: TBIO - Translate Bio, Inc.

Yield per half year: -89.87%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Translate Bio, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Translate Bio, Inc.

Translate Bio, Inc., терапевтическая компания, занимающаяся лечением матричной РНК (мРНК) на клинической стадии, разрабатывает лекарства для лечения заболеваний, вызванных дисфункцией белков или генов. Компания разрабатывает MRT5005, который проходит фазу I / II клинических испытаний для лечения муковисцидоза; и MRT5201 для лечения дефицита орнитин-транскарбамилазы. Компания ранее была известна как RaNA Therapeutics, Inc. и сменила название на Translate Bio, Inc. в июне 2017 года. Translate Bio, Inc. была основана в 2011 году, ее штаб-квартира находится в Лексингтоне, штат Массачусетс.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-06-18
ISIN US74019L5030
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.translate.bio
Цена ао 0.45
Change price per day: +37.93% (0.29)
Change price per week: -4.76% (0.42)
Change price per month: +5.26% (0.38)
Change price per 3 month: -73.68% (1.52)
Change price per half year: -89.87% (3.95)
Change price per year: -93.46% (6.12)
Change price per 3 year: -98.93% (37.36)
Change price per 5 year: -97.89% (18.98)
Change price per 10 year: 0% (0.4)
Change price per year to date: +5.26% (0.38)
All parameters

Underestimation

Title Value Grade
P/S 7.71 1
P/BV 7.18 1
P/E 64.4 1
EV/EBITDA -7.88 0
Total: 3.88

Efficiency

Title Value Grade
ROA, % -67.78 0
ROE, % -161.57 0
Total: 0.6667

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.2284 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 252.68 10
Yield Ebitda, % -62.85 0
Yield EPS, % 1208.11 10
Total: 4
More

Institutions Volume Share, %
Northpond Ventures, Llc 9844130 32.7
Vanguard Group Inc 418293 1.39
Penbrook Management LLC 354325 1.18
Millennium Management LLC 297524 0.99
Geode Capital Management, LLC 83561 0.28
Bridgeway Capital Management, Inc. 67000 0.22
Vontobel Holding Limited 50000 0.17
Citadel Advisors Llc 37486 0.12
Renaissance Technologies, LLC 27547 0.09
Blackrock Inc. 25857 0.09



Head Job title Payment Year of birth
Mr. Daniel G. Gibson Ph.D. Chief Technology Officer 590.37k 1977 (48 years)
Ms. Jen Carroll Vice President of Investor Relations N/A
Mr. Robert H. Cutler Chief Legal Officer 568.58k 1968 (57 years)
Mr. Decky Goodrich M.B.A. Senior Vice President of Corporate Development N/A
Richard Lepke Director of Investor Relations N/A
Mr. William J. Kullback Chief Financial Officer N/A 1960 (65 years)
Mr. Eric Esser President, CEO, COO & Chairman 1968 (57 years)

Address: United States, Lexington, MA , 29 Hartwell Avenue - open in Google maps, open in Yandex maps
Website: http://www.translate.bio